|
1. |
American Journal of Therapeutics |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 1-1
John Somberg,
Preview
|
|
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
2. |
Bioterrorism 2002 |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 3-3
John Somberg,
Preview
|
|
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
3. |
Biological and Chemical Agents: A Brief Synopsis |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 5-14
Mark Rosenbloom,
Jerrold Leikin,
Stephen Vogel,
Zafar Chaudry,
Preview
|
PDF (906KB)
|
|
摘要:
The objective of this article is to provide a concise overview of the most likely biological and chemical agents that could be used as biochemical weapons. The diagnosis, pathology, prevention, decontamination, treatment, and disposition of these biological and chemical agents are presented in a tabular format for quick reference purposes. The information provided outlines the bare essentials needed to deal with any emergency or catastrophic event involving these agents.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
4. |
Salivary and Urinary Excretion and Plasma–Saliva Concentration Ratios of Isoniazid in the Presence of Co-administered Ciprofloxacin |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 15-18
Sabinus Ofoefule,
Chioma Obodo,
Orish Orisakwe,
Johnson Afonne,
Ndidiamaka Ilondu,
Patrick Agbasi,
Chikere Anusiem,
Steve Maduka,
Cajetan Ilo,
Preview
|
PDF (806KB)
|
|
摘要:
Salivary and urinary excretion and plasma–saliva concentration ratios of isoniazid (INH) in the absence and presence of ciprofloxacin (CP) were investigated in healthy female volunteers. Results obtained indicated an absorption form of interaction between INH and CP. This led to delay in gastric emptying and onset of absorption of INH in the upper part of the gastrointestinal tract, resulting in a corresponding delay in the onset of salivary and urinary excretion of the drugs. There was a 1-hour reduction in the time to attain peak saliva concentration of INH (tmax), an insignificant difference in peak saliva concentration (Cmax), and a significant (P= 0.05) increase in AUC(0–24h)of INH in the presence of CP. Cumulative amount of INH excreted in the urine increased approximately 38% in the presence of CP. The calculated plasma–saliva concentration ratios of INH were reduced in the presence of CP and were slightly lower than the experimental values. This indicates increased amount of the drug secreted into saliva in the presence of CP and possible buccal partitioning of the drug. Overall, results of the current study indicate that CP delayed the onset but not the extent of INH absorption. Therefore, concurrent administration of the two drugs was considered relatively safe, and the absorption interaction that may have occurred may not be of reasonable clinical consequence.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
5. |
Rapid Determination of Partition Coefficients Between n-Octanol/Water for Cardiovascular Therapies |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 19-24
Vasant Ranade,
John Somberg,
Preview
|
PDF (558KB)
|
|
摘要:
The lipid solubility of a pharmaceutical may greatly influence its tissue activity. To evaluate lipid solubility of a group of cardiovascular agents a procedure to determine partition coefficients in n-octanol/water for a series of cardiovascular compounds was described. Ultraviolet absorbance measurements were used to assess partitioning between the two liquid phases of these compounds. In this study, sotalol was found to be the most hydrophilic (n-octanol/water ratio of 0.33) and fosinopril-sodium was the most lipophilic (ratio of 6.19). This is a versatile method permitting the evaluation of lipophilicity and, thus, parameters governing the events leading to pharmacologic actions such as gastrointestinal dissolution, absorption, and bioavailability. These observations can be related to a drug series, composed of several compounds having structural similarities or minor variations. The lipid solubility of a compound can markedly alter its side-effects profile, especially because lipophilic drugs enter the central nervous system with facility. Additionally, lipophilic agents may enter target tissue with greater ease than nonlipophilic compounds and thus possess local intracellular effects in addition to a macro systemic action.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
6. |
Serum Iron, Transferrin Saturation, Ferritin, and Dietary Data in Age-Related Macular Degeneration |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 25-28
Stuart Richer,
David Rudy,
Laisvyde Statkute,
Kurt Karofty,
Jim Frankowski,
Preview
|
PDF (384KB)
|
|
摘要:
Iron (Fe) is a tightly metabolically controlled mineral and growth factor for all living cells. Iron not bound in erythrocyte hemoglobin is transported by the plasma iron transport protein transferrin (Tf) and bound within cells by ferritin. Apo-Tf and apo-hemopexin are also known to be made locally in the retina. Free Fe is cytotoxic, promotes oxidation/lipid peroxidation, has been implicated as a risk factor in cardiac disease, and is itself associated with age-related macular degeneration (ARMD), the leading cause of blindness in aging western societies. The authors evaluated Fe overload serum markers and dietary intake in patients with atrophic ARMD. After obtaining informed consent, an Fe panel consisting of serum Fe, total Fe binding capacity (TIBC), and ferritin was performed on 75 veterans (70 men, five women) with an average age of 75 years with a diagnosis of atrophic ARMD by combined criteria of International Retinal Classification and psychophysical/symptom abnormalities. Tf saturation was calculated by dividing serum Fe concentration by TIBC. Dietary iron with and without supplementation and vitamin C intake were determined for 86 patients using the Harvard School of Public Health/Department of Nutrition Food Frequency Questionnaire. Statistically significant correlations (P<0.1) were found between serum and dietary Fe (r= −.26), between serum Fe and serum ferritin (r= .34), and between dietary Fe and dietary vitamin C (r= .30). The data on mostly male geriatric veterans with atrophic ARMD indicate that single time-point assessment of systemic Fe status and dietary Fe is not useful. However, serial multiple-year data, correlating Fe markers with disease, may still be important. Also, because Fe transport proteins do not cross the blood–retina barrier, the local cellular toxic effects of Fe must also be considered.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
7. |
4-Aminopyridine Influences Heart Rate Variability in Long-Standing Spinal Cord Injury |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 29-33
Jack Segal,
Alberta Warner,
Sherry Brunnemann,
David Bunten,
Preview
|
PDF (469KB)
|
|
摘要:
Humans with traumatic spinal myelopathy exhibit intralesional conduction block and autonomic failure as pathophysiologic sequelae of their injury. Analysis of heart rate variability (HRV) provides a means of assessing changes in the function of the autonomic nervous system (ANS) and the cardiac sequelae of injury. Thirteen patients with long-standing spinal cord injury (SCI) and 13 able-bodied controls were studied. Each patient received a single 10-mg dose of an immediate release (IR) formulation of 4-aminopyridine (4-AP). Twenty-four hour heart rate (HR) and HRV data were acquired using a Holter ambulatory electrocardiographic (ECG) monitor. Analysis of acquired data was carried out using a minicomputer programmed to separate ECG R-R intervals into frequency patterns that appear as peaks dispersed along a frequency range of 0.0 to 1.0 Hz. Twenty-four hour baseline, pretreatment low-frequency (LF) HRV power was diminished in all patients with SCI compared with able-bodied-controls and was significantly decreased in tetraplegic patients (P= 0.03). This difference in LF HRV power disappeared during the 24 hours immediately after administration of 4-AP, and mean LF HRV power in tetraplegic patients became indistinguishable from LF HRV power in controls. 4-Aminopyridine appears to influence ANS function and LF HRV in humans with long-standing SCI.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
8. |
Interspecies Scaling: Predicting Oral Clearance in Humans |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 35-42
Iftekhar Mahmood,
Preview
|
PDF (727KB)
|
|
摘要:
The objective of this study was to test the interspecies scaling approach for a wide variety of drugs to predict oral clearance in humans from animal data. This study is an attempt to evaluate whether the rule of exponents of Mahmood and Balian for the prediction of systemic clearance can also be applied for the prediction of oral clearance in humans. Three different methods were used to generate log-log plots to scale up the clearance values: (1) clearance versus body weight (simple allometric equation), (2) the product of clearance and maximum life-span potential (MLP) versus body weight, and (3) the product of clearance and brain weight versus body weight. Data from 32 drugs were analyzed, and it was concluded that the oral clearance of drugs could be best predicted using one of the allometric equations.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
9. |
Valdecoxib, a COX-2–Specific Inhibitor, Is an Efficacious, Opioid-Sparing Analgesic in Patients Undergoing Hip Arthroplasty |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 43-51
Frederic Camu,
Tessa Beecher,
David Recker,
Kenneth Verburg,
Preview
|
PDF (1612KB)
|
|
摘要:
Opioid agents are highly effective analgesics after orthopedic surgery but are associated with several adverse effects. Valdecoxib is a new, highly selective cyclooxygenase (COX)-2–specific inhibitor with a rapid onset of action and significant analgesic properties that is being developed for the management of acute pain. The objective of this study was to demonstrate the opioid-sparing efficacy of valdecoxib as part of a multimodal treatment of pain associated with hip arthroplasty. This multicenter, multiple-dose, double-blind, parallel-group study compared the opioid-sparing effects, analgesic efficacy, and safety of 20-and 40-mg doses of valdecoxib twice daily with placebo in patients receiving morphine by patient-controlled analgesia after hip arthroplasty. Study medication was first administered 1 to 3 hours preoperatively. The total amount of morphine administered, pain intensity, and patient's global evaluation of study medication were assessed over a period of 48 hours. Patients receiving 20 or 40 mg valdecoxib twice daily required on average 40% less morphine than those receiving placebo after hip arthroplasty. Pain intensity levels and patient satisfaction were significantly improved in both valdecoxib groups compared with placebo. Valdecoxib and placebo were equally well tolerated. Pre-and postoperative administration of valdecoxib reduces the amount of morphine required for postoperative pain relief and provides greater analgesic efficacy compared with morphine alone. Thus, valdecoxib has significant clinical utility for acute pain management in orthopedic surgery patients.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
10. |
Meperidine: A Critical Review |
|
American Journal of Therapeutics,
Volume 9,
Issue 1,
2002,
Page 53-68
Kenneth Latta,
Brian Ginsberg,
Robert Barkin,
Preview
|
PDF (1428KB)
|
|
摘要:
Meperidine was initially synthesized as an anticholinergic agent but was soon discovered to have analgesic properties. Although meperidine's anticholinergic effects were demonstrated in vivo, the anticholinergic effects on the biliary and renal tracts have not been demonstrated in vivo. Studies have clearly demonstrated that meperidine is no more efficacious in treating biliary or renal tract spasm than comparative mu opioids. The initial studies demonstrating the analgesic efficacy of meperidine were mostly case reports and not double-blind, randomized, controlled trials in specific populations. Subsequent comparative studies failed to demonstrate any advantages of meperidine over comparable doses of other analgesics. Meperidine was portrayed in practice and teaching as having unique clinical advantages. The analgesic effects of meperidine are not pronounced, and, in addition, meperidine use is complicated by unique side effects including serotonergic crisis and normeperidine toxicity. Meperidine's poor efficacy, toxicity, and multiple drug interactions have resulted in a movement to replace meperidine with more efficacious and less toxic opioid analgesics.
ISSN:1075-2765
出版商:OVID
年代:2002
数据来源: OVID
|
|